GGrantIndex
← Leaderboards

Jennifer Lynn Bizon

Johns Hopkins University

$9,186,341
Attributed
$17,647,676
Total exposure
10
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.4M · FY200725
$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$17,647,676 · 10

By mechanism

RF1$8,693,918 · 3
R01$7,157,122 · 3
T32$1,287,117 · 2
R21$419,375 · 1
F32$90,144 · 1

Most similar at Johns Hopkins University

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos

Research focus

Alzheimer&AposCognitionAgingAgedImpaired CognitionAttenuatedRattusSignal TransductionCognitiveAge RelatedImpairmentAffectS DiseaseProgramsAge-Associated Memory ImpairmentLinkStructureCognitive DeficitsSynapsesBiochemicalNeurobiologyFunctional DisorderMemoryShort-Term Memory

Grant awards (34)

Mechanisms and therapeutic potential of vagus nerve stimulation in aging and Alzheimer’s disease$535,654
R01 · FY2025 · AG · contact PI
Effects of cannabis on age-related cognitive decline and Alzheimers disease pathology$510,214
R01 · FY2025 · AG
Broad-based Research, Analytics and Innovation in Neuroscience (B2RAIN) predoctoral Training Program$268,155
T32 · FY2025 · NS · contact PI
Effects of cannabis on age-related cognitive decline and Alzheimers disease pathology$591,891
R01 · FY2024 · AG
Mechanisms and therapeutic potential of vagus nerve stimulation in aging and Alzheimer’s disease$546,586
R01 · FY2024 · AG · contact PI
Broad-based Research, Analytics and Innovation in Neuroscience (B2RAIN) predoctoral Training Program$110,844
T32 · FY2024 · NS · contact PI
Effects of cannabis on age-related cognitive decline and Alzheimers disease pathology$676,835
R01 · FY2023 · AG
Effects of cannabis on age-related cognitive decline and Alzheimers disease pathology$604,355
R01 · FY2022 · AG
Clinical and Translational Pre-doctoral training in Alzheimer's Disease and Related Dementias$77,698
T32 · FY2022 · AG
Mechanisms and therapeutic potential of vagus nerve stimulation in aging and Alzheimer’s disease$1,715,806
RF1 · FY2021 · AG · contact PI
Effects of cannabis on age-related cognitive decline and Alzheimers disease pathology$604,355
R01 · FY2021 · AG
Clinical and Translational Pre-doctoral training in Alzheimer's Disease and Related Dementias$178,288
T32 · FY2021 · AG
Clinical and Translational Pre-doctoral training in Alzheimer's Disease and Related Dementias$176,058
T32 · FY2020 · AG
Immunotherapy targeting the HPA axis in Alzheimer’s disease$2,689,784
RF1 · FY2019 · AG
Immunotherapy targeting the HPA axis in Alzheimer's disease$1,283,668
RF1 · FY2019 · AG
Interactions of Perirhinal Tau Pathology and Aging in Cognitive Dysfunction$228,750
R21 · FY2019 · AG · contact PI
Clinical and Translational Pre-doctoral training in Alzheimer's Disease and Related Dementias$173,881
T32 · FY2019 · AG
Decision making and basolateral amygdala dysfunction in aging$3,004,660
RF1 · FY2018 · AG · contact PI
Neural Mechanisms of Cognitive Decline in Aging$303,060
R01 · FY2018 · AG · contact PI
Clinical and Translational Pre-doctoral training in Alzheimer's Disease and Related Dementias$302,193
T32 · FY2018 · AG
Interactions of Perirhinal Tau Pathology and Aging in Cognitive Dysfunction$190,625
R21 · FY2018 · AG · contact PI
Neural Mechanisms of Cognitive Decline in Aging$303,640
R01 · FY2017 · AG · contact PI
Neural Mechanisms of Cognitive Decline in Aging$304,143
R01 · FY2016 · AG · contact PI
Neural Mechanisms of Cognitive Decline in Aging$360,373
R01 · FY2015 · AG · contact PI
Neural Mechanisms of Cognitive Decline in Aging$304,627
R01 · FY2014 · AG · contact PI
2RO1AG029421 Neural Mechanisms of Age-related cognitive decline$66,938
R01 · FY2014 · AG · contact PI
Basal forebrain and cognitive aging: Novel experimental and theraptutic avenues$277,501
R01 · FY2011 · AG · contact PI
Basal forebrain and cognitive aging: Novel experimental and theraptutic avenues$272,638
R01 · FY2010 · AG · contact PI
Basal forebrain and cognitive aging: Novel experimental and theraptutic avenues$14,133
R01 · FY2010 · AG · contact PI
Basal forebrain and cognitive aging: Novel experimental and theraptutic avenues$288,132
R01 · FY2009 · AG · contact PI
Basal forebrain and cognitive aging: Novel experimental and theraptutic avenues$287,385
R01 · FY2008 · AG · contact PI
Basal forebrain and cognitive aging: Novel experimental and theraptutic avenues$304,662
R01 · FY2007 · AG · contact PI
Neurogenesis in an Animal Model of Cognitive Aging$48,148
F32 · FY2002 · AG
Neurogenesis in an Animal Model of Cognitive Aging$41,996
F32 · FY2001 · AG